Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Paracetamol use during pregnancy is linked to changed reproductive development in daughters

09 September 2026

Human Reproduction Open Press Release
Researchers in Denmark have found that girls whose mothers took paracetamol during pregnancy had smaller ovaries, fewer ovarian follicles (the structures that contain immature eggs), smaller uteruses and lower levels of reproductive hormones at three months old.

Vanillin flavouring in e-cigarettes disrupts human embryonic stem cell development

13 August 2026

Human Reproduction Press Release
Vanillin, a common flavouring chemical in e-cigarettes, may disrupt the normal development of embryos in pregnant women who vape, according to a study published in Human Reproduction.

New Council of Europe recommendation on gamete donor protection

24 July 2026

The Council of Europe has recently adopted a recommendation on establishing harmonised measures for the protection of third-party gamete donors, which was developed in collaboration with ESHRE.

ESHRE has set out its position and policy recommendations on international limits on the number of offspring per gamete donor

08 July 2026

Position statement
This position paper describes relevant principles that should be considered in debates surrounding international limits on the number of offspring born from a single gamete donor and sets out ESHRE’s position and policy recommendations on this topic, particularly focusing on the European Union.